|
|
|
|
| LEADER |
01000cas a22002652 4500 |
| 001 |
NLM120490560 |
| 003 |
DE-627 |
| 005 |
20240314233041.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231222d20012024xx u| |o 0 |0und c |
| 022 |
|
|
|a 1873-5576
|
| 022 |
|
|
|a 1568-0096
|
| 035 |
|
|
|a (DE-627)NLM120490560
|
| 035 |
|
|
|a (NLM)101094211
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 210 |
1 |
0 |
|a Curr Cancer Drug Targets
|
| 245 |
1 |
0 |
|a Current cancer drug targets
|
| 264 |
3 |
1 |
|c 2001-2024
|
| 336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
| 337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
| 338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
| 912 |
|
|
|a GBV_NLM
|
| 951 |
|
|
|a JT
|
